查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1667860

烏洛托品市場 - 全球產業規模、佔有率、趨勢、機會和預測，按最終用途、按銷售管道、按地區和競爭細分，2020-2035 年

Methenamine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By End-Use, By Sales Channel, By Region and Competition, 2020-2035F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球烏洛托品市場價值為 502.72 萬噸，預計到 2035 年將達到 740.94 萬噸，預測期內年複合成長率(CAGR) 為 3.59%。

市場概況
預測期 2026-2035
2024 年市場規模 502.72 千噸
2035 年市場規模 740.94 千噸
2025-2035 年複合年成長率 3.59％
成長最快的領域 合成樹脂
最大的市場 亞太地區

全球烏洛托品市場充滿活力，並受到跨各行各業廣泛應用的推動。六亞甲基四胺，也稱為六亞甲基四胺，廣泛用於藥品、塑膠和消毒劑。在製藥領域，它在治療泌尿道感染（UTI）方面發揮關鍵作用，具有對抗特定細菌菌株的抗菌特性。根據世界衛生組織（WHO）的報告，細菌感染對常用抗生素的抗藥性日益增強，導致需求增加。超過 60% 的淋病奈瑟菌分離株（性傳染感染的主要原因）對廣泛使用的抗生素環丙沙星表現出抗藥性。此外，超過 20% 的大腸桿菌分離株（導致泌尿道感染的主要原因）對第一線（氨芐西林、複方新諾明）和二線（氟喹諾酮類）治療均表現出抗藥性。

主要市場促進因素

製藥領域對烏洛托品的需求不斷成長

主要市場挑戰

監管障礙和合規問題

主要市場趨勢

烏洛托品生產技術進步

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第 5 章：全球烏洛托品市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依最終用途分類（合成樹脂、橡膠工業、紡織業及其他）
    • 按銷售管道（直接銷售和間接銷售）
    • 按公司分類（2024）
    • 按地區
  • 市場地圖

第 6 章：北美烏洛托品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 墨西哥
    • 加拿大

第 7 章：歐洲烏洛托品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區烏洛托品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美烏洛托品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲烏洛托品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如果有）
  • 最新動態

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Shandong Shengxuelong Chemical Co., Ltd.
  • UCC Shchekinoazot
  • Sina Chemical Industries Company
  • Henan Runhua Chemicals Co.,Ltd
  • Guangzhou Hanpu Pharmaceutical Co Ltd
  • Zaozhuang xudong chemical technology co., ltd.
  • Simalin Chemical Industries Private Limited

第 15 章：策略建議

第16章 關於出版商,免責事項

簡介目錄
Product Code: 27522

The global Methenamine market was valued at 502.72 thousand tonnes in 2024 and is projected to reach 740.94 thousand tonnes by 2035, registering a Compound Annual Growth Rate (CAGR) of 3.59% over the forecast period.

Market Overview
Forecast Period2026-2035
Market Size 2024502.72 Thousand Tonnes
Market Size 2035740.94 Thousand Tonnes
CAGR 2025-20353.59%
Fastest Growing SegmentSynthetic Resin
Largest MarketAsia- Pacific

The global Methenamine market is dynamic and driven by its broad range of applications across various industries. Methenamine, also known as hexamethylenetetramine, is widely used in pharmaceuticals, plastics, and as a disinfectant. In the pharmaceutical sector, it plays a critical role in treating urinary tract infections (UTIs), offering antimicrobial properties that combat specific bacterial strains. According to a World Health Organization (WHO) report, the growing resistance to common antibiotics in bacterial infections is contributing to increased demand. Over 60% of Neisseria gonorrhoeae isolates, a major cause of sexually transmitted infections, have shown resistance to ciprofloxacin, a widely used antibiotic. Additionally, more than 20% of E. coli isolates, a leading cause of UTIs, demonstrate resistance to both first-line (ampicillin, co-trimoxazole) and second-line (fluoroquinolones) treatments.

Key Market Drivers

Growing Demand for Methenamine in Pharmaceutical Applications

One of the main drivers of the global Methenamine market is its increasing use in the pharmaceutical industry, especially for its antimicrobial properties in treating UTIs. As UTIs remain one of the most common bacterial infections worldwide, the rising prevalence of these infections, particularly among women and the elderly, is fueling demand for Methenamine-based treatments. Methenamine is highly effective at preventing bacterial growth in the urinary tract and is frequently prescribed in combination with other drugs to enhance its therapeutic effects. In September 2024, Mankind Pharma Ltd. introduced its RAPID NEWS self-test kits to address prevalent health concerns such as UTIs, dengue, and early menopause. This innovation aims to make healthcare more accessible by offering individuals across India a convenient, private, and rapid testing solution.

Key Market Challenges

Regulatory Hurdles and Compliance Issues

The global Methenamine market faces significant regulatory challenges, which may hinder its growth. Methenamine, due to its classification as a chemical compound with multiple industrial applications, is subject to stringent regulations across different countries. These regulations primarily focus on safety standards, environmental impact, and potential risks to human health. Governments in regions such as the European Union, North America, and Asia Pacific have imposed limits on the manufacturing and use of chemicals like Methenamine due to concerns over their toxicity and environmental effects. Companies in this sector must navigate complex regulatory frameworks, including safety certifications, environmental approvals, and product registrations, which can delay time-to-market and increase operational costs. Additionally, the evolving nature of regulatory policies and the potential introduction of new laws add uncertainty to the market landscape.

Key Market Trends

Technological Advancements in Methenamine Production

Technological innovations in Methenamine production are driving the expansion of the global market. As demand for Methenamine grows across various industries, more efficient and cost-effective manufacturing processes are essential to meet market needs. New advancements in production technologies, such as sustainable manufacturing methods and improved reaction conditions, have significantly reduced production costs and increased output. This has made Methenamine more accessible to industries requiring large quantities of the compound.

Key Market Players

  • Shandong Shengxuelong Chemical Co., Ltd.
  • UCC Shchekinoazot
  • Sina Chemical Industries Company
  • Henan Runhua Chemicals Co., Ltd.
  • Guangzhou Hanpu Pharmaceutical Co. Ltd
  • Zaozhuang Xudong Chemical Technology Co., Ltd.
  • Simalin Chemical Industries Private Limited

Report Scope

This report segments the Global Methenamine Market into the following categories, along with detailed insights into industry trends:

Methenamine Market by End-Use:

  • Synthetic Resin
  • Rubber Industry
  • Textile Industry
  • Other Industries

Methenamine Market by Sales Channel:

  • Direct Sales
  • Indirect Sales

Methenamine Market by Region:

  • North America: United States, Canada, Mexico
  • Europe: France, United Kingdom, Italy, Germany, Spain
  • Asia-Pacific: China, India, Japan, Australia, South Korea
  • South America: Brazil, Argentina, Colombia
  • Middle East & Africa: South Africa, Saudi Arabia, UAE

Competitive Landscape

Company Profiles: In-depth analysis of the leading companies operating in the Global Methenamine Market.

Available Customizations:

The Global Methenamine Market report can be customized based on specific company needs. Customization options include:

  • Company Information: Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Methenamine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By End-Use (Synthetic Resin, Rubber Industry, Textile Industry, and Others)
    • 5.2.2. By Sales Channel (Direct Sale and Indirect Sale)
    • 5.2.3. By Company (2024)
    • 5.2.4. By Region
  • 5.3. Market Map

6. North America Methenamine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By End-Use
    • 6.2.2. By Sales Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Methenamine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By End-Use
        • 6.3.1.2.2. By Sales Channel
    • 6.3.2. Mexico Methenamine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By End-Use
        • 6.3.2.2.2. By Sales Channel
    • 6.3.3. Canada Methenamine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By End-Use
        • 6.3.3.2.2. By Sales Channel

7. Europe Methenamine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By End-Use
    • 7.2.2. By Sales Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Methenamine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By End-Use
        • 7.3.1.2.2. By Sales Channel
    • 7.3.2. Germany Methenamine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By End-Use
        • 7.3.2.2.2. By Sales Channel
    • 7.3.3. United Kingdom Methenamine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By End-Use
        • 7.3.3.2.2. By Sales Channel
    • 7.3.4. Italy Methenamine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By End-Use
        • 7.3.4.2.2. By Sales Channel
    • 7.3.5. Spain Methenamine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By End-Use
        • 7.3.5.2.2. By Sales Channel

8. Asia-Pacific Methenamine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By End-Use
    • 8.2.2. By Sales Channel
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Methenamine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By End-Use
        • 8.3.1.2.2. By Sales Channel
    • 8.3.2. India Methenamine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By End-Use
        • 8.3.2.2.2. By Sales Channel
    • 8.3.3. South Korea Methenamine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By End-Use
        • 8.3.3.2.2. By Sales Channel
    • 8.3.4. Japan Methenamine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By End-Use
        • 8.3.4.2.2. By Sales Channel
    • 8.3.5. Australia Methenamine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By End-Use
        • 8.3.5.2.2. By Sales Channel

9. South America Methenamine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By End-Use
    • 9.2.2. By Sales Channel
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Methenamine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By End-Use
        • 9.3.1.2.2. By Sales Channel
    • 9.3.2. Argentina Methenamine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By End-Use
        • 9.3.2.2.2. By Sales Channel
    • 9.3.3. Colombia Methenamine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By End-Use
        • 9.3.3.2.2. By Sales Channel

10. Middle East and Africa Methenamine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By End-Use
    • 10.2.2. By Sales Channel
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Methenamine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By End-Use
        • 10.3.1.2.2. By Sales Channel
    • 10.3.2. Saudi Arabia Methenamine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By End-Use
        • 10.3.2.2.2. By Sales Channel
    • 10.3.3. UAE Methenamine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By End-Use
        • 10.3.3.2.2. By Sales Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Shandong Shengxuelong Chemical Co., Ltd.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. UCC Shchekinoazot
  • 14.3. Sina Chemical Industries Company
  • 14.4. Henan Runhua Chemicals Co.,Ltd
  • 14.5. Guangzhou Hanpu Pharmaceutical Co Ltd
  • 14.6. Zaozhuang xudong chemical technology co., ltd.
  • 14.7. Simalin Chemical Industries Private Limited

15. Strategic Recommendations

16. About Us & Disclaimer